PMID- 21751552
OWN - NLM
STAT- MEDLINE
DCOM- 20111213
LR  - 20191210
IS  - 1426-9686 (Print)
IS  - 1426-9686 (Linking)
VI  - 30
IP  - 180
DP  - 2011 Jun
TI  - [Intravenous immunoglobulin therapy for kidney diseases in children].
PG  - 423-6
AB  - Intravenous immunoglobulin (IVIG) for the treatment of primary immunodeficiency 
      disorders have been administrated for more than 25 years. However, the 
      recognition of the anti-inflammatory and immune-modulatory actions of IVIG 
      resulted broader applications to autoimmunity and systemic inflammatory 
      conditions. The major focus of this review is the usefulness of IVIG therapy in 
      children kidney disease, particularly in severe, atypical hemolytic-uremic 
      syndrome and thrombotic thrombocytopenic purpura, refractory to standard therapy, 
      including plasmaferesis. The role of intravenous immunoglobulins in the treatment 
      and prevention of infection, the most common complication in nephrotic syndrome 
      is also discussed. Probably, in the future, similarly to adults, IVIG will be 
      used for the therapy of some forms of glomerulopathies.
FAU - Zwolinska, Danuta
AU  - Zwolinska D
AD  - Akademia Medyczna we Wroclawiu, Katedra i Klinika Nefrologii Pediatrycznej. 
      zwolin@nefped.am.wroc.pl
LA  - pol
PT  - Journal Article
PT  - Review
TT  - Terapia dozylnymi preparatami immunoglobulin w chorobach nerek u dzieci.
PL  - Poland
TA  - Pol Merkur Lekarski
JT  - Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego
JID - 9705469
RN  - 0 (Anti-Inflammatory Agents)
RN  - 0 (Immunoglobulins, Intravenous)
RN  - 0 (Immunologic Factors)
SB  - IM
MH  - Anti-Inflammatory Agents/*administration & dosage
MH  - Child
MH  - Hemolytic-Uremic Syndrome/complications/*drug therapy/immunology
MH  - Humans
MH  - Immunization, Passive
MH  - Immunoglobulins, Intravenous/*administration & dosage
MH  - Immunologic Factors/*administration & dosage
MH  - Infection Control/methods
MH  - Infections/etiology
MH  - Nephrotic Syndrome/complications/*drug therapy/immunology
MH  - Purpura, Thrombotic Thrombocytopenic/complications/*drug therapy/immunology
EDAT- 2011/07/15 06:00
MHDA- 2011/12/14 06:00
CRDT- 2011/07/15 06:00
PHST- 2011/07/15 06:00 [entrez]
PHST- 2011/07/15 06:00 [pubmed]
PHST- 2011/12/14 06:00 [medline]
PST - ppublish
SO  - Pol Merkur Lekarski. 2011 Jun;30(180):423-6.